Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$305M Sell
5,518,433
-2,598,094
-32% -$141M 0.74% 26
2025
Q4
$398M Buy
8,116,527
+1,016,107
+14% +$47.4M 0.84% 20
2025
Q3
$306M Buy
7,100,420
+1,490,889
+27% +$58.2M 0.7% 34
2025
Q2
$215M Buy
5,609,531
+304,489
+6% +$11.6M 0.53% 54
2025
Q1
$206M Buy
5,305,042
+4,792,922
+936% +$175M 0.61% 47
2024
Q4
$17.3M Buy
512,120
+446,819
+684% +$16.1M 0.06% 265
2024
Q3
$2.67M Sell
65,301
-5,624,394
-99% -$230M 0.01% 501
2024
Q2
$219M Sell
5,689,695
-3,029,949
-35% -$127M 0.92% 20
2024
Q1
$374M Buy
8,719,644
+495,096
+6% +$20.4M 1.38% 4
2023
Q4
$305M Buy
8,224,548
+3,210,489
+64% +$115M 1.19% 8
2023
Q3
$182M Buy
5,014,059
+2,096,223
+72% +$74.4M 0.81% 30
2023
Q2
$104M Buy
2,917,836
+1,735,217
+147% +$62.2M 0.45% 78
2023
Q1
$42.1M Buy
+1,182,619
New +$41.4M 0.21% 146
2022
Q3
Sell
-200,000
Closed -$10.9M 861
2022
Q2
$10.9M Buy
+200,000
New +$11M 0.07% 209

Other funds holding GSK